These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36791846)

  • 1. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
    Li J; Wang Y; Solanki K; Atre R; Lavrijsen M; Pan Q; Baig MS; Li P
    Antiviral Res; 2023 Mar; 211():105555. PubMed ID: 36791846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressants exert differential effects on pan-coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir.
    Wang Y; Li P; Lavrijsen M; Rottier RJ; den Hoed CM; Bruno MJ; Kamar N; Peppelenbosch MP; de Vries AC; Pan Q
    United European Gastroenterol J; 2023 Jun; 11(5):431-447. PubMed ID: 37226653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of
    Tong X; Keung W; Arnold LD; Stevens LJ; Pruijssers AJ; Kook S; Lopatin U; Denison M; Kwong AD
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0084023. PubMed ID: 37800975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
    Weil T; Lawrenz J; Seidel A; Münch J; Müller JA
    Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids.
    Li P; Wang Y; Lamers MM; Lavrijsen M; Iriondo C; de Vries AC; Rottier RJ; Peppelenbosch MP; Haagmans BL; Pan Q
    EBioMedicine; 2022 Jul; 81():104132. PubMed ID: 35779493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
    Wang Y; Li P; Solanki K; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
    Virology; 2021 Dec; 564():33-38. PubMed ID: 34619630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir.
    Zhang Y; Sun Y; Xie Y; Shang W; Wang Z; Jiang H; Shen J; Xiao G; Zhang L
    Signal Transduct Target Ther; 2023 Sep; 8(1):360. PubMed ID: 37735468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.
    Wang Y; Li P; Lavrijsen M; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
    Arch Virol; 2022 Apr; 167(4):1125-1130. PubMed ID: 35171357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating theobromine as a potential anti-human coronaviral agent.
    Li J; Wang Y; Rajpoot S; Lavrijsen M; Pan Q; Li P; Baig MS
    Microbiol Immunol; 2023 Sep; 67(9):404-412. PubMed ID: 37415325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M
    Dawood AA
    Adv Med Sci; 2023 Mar; 68(1):1-9. PubMed ID: 36368287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
    Hu Y; Jo H; DeGrado WF; Wang J
    J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
    Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
    Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
    [No Abstract]   [Full Text] [Related]  

  • 15. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
    Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
    Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
    Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters.
    Bakos É; Temesszentandrási-Ambrus C; Özvegy-Laczka C; Gáborik Z; Sarkadi B; Telbisz Á
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37510996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs.
    Saravolatz LD; Depcinski S; Sharma M
    Clin Infect Dis; 2023 Jan; 76(1):165-171. PubMed ID: 35245942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathic Effect Assay and Plaque Assay to Evaluate
    Hu Y; Ma C; Wang J
    Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants.
    Jiang H; Zhou Y; Zou X; Hu X; Wang J; Zeng P; Li W; Zeng X; Zhang J; Li J
    Biochemistry; 2023 Jul; 62(13):2055-2064. PubMed ID: 37222536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.